![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
Moderna Awarded $176 Million from the Biomedical Advanced Research and Development Authority to Expedite Development of mRNA-Based Influenza Vaccines
admin July 3, 2024 ArticleFunding from the Biomedical Advanced Research and Development Authority (BARDA) is expected to support the late-stage development and licensure of a pre-pandemic vaccine targeting the H5 influenza virus.
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
FDA Approves Lilly’s Kisunla for the Treatment of Early Symptomatic Alzheimer’s Disease
admin July 3, 2024 ArticleKisunla is the first amyloid plaque-targeting therapy that allows for stopping treatment upon plaque removal, company says.
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
As previously announced, Michael assumed the role on July 1.
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
FDA Approves New Drug Application for Shorla Oncology’s Tepylute, a Ready-to-Dilute Formulation for the Treatment of Breast and Ovarian Cancer
admin July 2, 2024 ArticleReportedly, the liquid formulation of Tepylute eliminates the need for complex and time-consuming reconstitution, providing consistent dosing accuracy and allowing for timely preparation.
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
Magnolia Medical Announces New Platform to Reduce Misdiagnosis of Sepsis
admin July 1, 2024 ArticleThe platform utilizes standards set forth in a recently published document from the CDC.
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
UltraSight Announces Partnership with Butterfly Garden AI-Marketplace
admin July 1, 2024 ArticleUltraSight will join the AI marketplace.
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
Pharma Pulse 6/28/24: Acupuncture Decreases Hot Flashes, The Benefits of Using AI in Data Management & more
admin June 30, 2024 ArticleThe latest news for pharma industry insiders.
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
FDA Approves Verona’s Ohtuvayre for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease
admin June 30, 2024 ArticleOhtuvayre is the first inhaled product with a novel mechanism of action for chronic obstructive pulmonary disease to be approved in 20 years.
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
With CEO Turnover Rising to Record Levels, How Can Incoming, Existing Executives Build a Sustainable Role?
admin June 29, 2024 ArticleA Q&A with Russell Reynolds’ Global Lead of CEO & Executive Transition Practice, Ty Wiggins, PhD.
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
CDC’s Advisory Committee Unanimously Recommends Vaxelis to Prevent Invasive Hemophilus Influenzae Type B in American Indian and Alaska Native Infants
admin June 29, 2024 ArticleThe inclusion of Vaxelis in the CDC’s preferential recommendations is expected to influence vaccine administration strategies and public health policies in high-risk populations moving forward.